Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
Willem Jespers, Ana Oliveira, Rubén Prieto‐Díaz, et al.
Molecules (2017) Vol. 22, Iss. 11, pp. 1945-1945
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning
Xuhan Liu, Kai Ye, Herman van Vlijmen, et al.
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 46
Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy Perturbation
Francesca Deflorian, Laura Pérez‐Benito, Eelke B. Lenselink, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 11, pp. 5563-5579
Closed Access | Times Cited: 75
Treatment of chronic neuropathic pain: purine receptor modulation
Kenneth A. Jacobson, Luigino Antonio Giancotti, Filomena Lauro, et al.
Pain (2020) Vol. 161, Iss. 7, pp. 1425-1441
Open Access | Times Cited: 63
Targeting adenosine A2A receptor antagonism for treatment of cancer
Miles Congreve, Giles A. Brown, Alexandra Borodovsky, et al.
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 11, pp. 997-1003
Closed Access | Times Cited: 53
Design of Drug Efficacy Guided by Free Energy Simulations of the β2‐Adrenoceptor
Nicolas Panel, Duc Duy Vo, Nour Aldin Kahlous, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 15
Ligand and Residue Free Energy Perturbations Solve the Dual Binding Mode Proposal for an A2BAR Partial Agonist
Tana Tandarić, Hugo Gutiérrez‐de‐Terán
The Journal of Physical Chemistry B (2025)
Open Access
QresFEP: An Automated Protocol for Free Energy Calculations of Protein Mutations in Q
Willem Jespers, Geir Villy Isaksen, Tor Arne Heim Andberg, et al.
Journal of Chemical Theory and Computation (2019) Vol. 15, Iss. 10, pp. 5461-5473
Open Access | Times Cited: 38
General structure-activity relationship models for the inhibitors of Adenosine receptors: A machine learning approach
Mona Janbozorgi, Sara Kaveh, M. S. Neiband, et al.
Molecular Diversity (2025)
Closed Access
X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists
Willem Jespers, Grégory Verdon, Jhonny Azuaje, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 38, pp. 16536-16543
Open Access | Times Cited: 30
Quantum Mechanical-Cluster Approach to Solve the Bioisosteric Replacement Problem in Drug Design
Timofey V. Losev, Igor S. Gerasimov, Maria V. Panova, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 4, pp. 1239-1248
Closed Access | Times Cited: 10
Alchemical Free Energy Calculations on Membrane-Associated Proteins
Michail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 21, pp. 7437-7458
Open Access | Times Cited: 10
Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design
Veronica Salmaso, Kenneth A. Jacobson
ChemMedChem (2020) Vol. 15, Iss. 21, pp. 1958-1973
Open Access | Times Cited: 25
Structure-based virtual screening discovers potent and selective adenosine A1 receptor antagonists
Pierre Matricon, Thi Nguyen, Duc Duy Vo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115419-115419
Open Access | Times Cited: 8
Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends
Nizar A. Al‐Shar’i, Qosay Al‐Balas
Current Pharmaceutical Design (2019) Vol. 25, Iss. 7, pp. 783-816
Closed Access | Times Cited: 25
Free Energy Calculations for Protein–Ligand Binding Prediction
Willem Jespers, Johan Åqvist, Hugo Gutiérrez‐de‐Terán
Methods in molecular biology (2021), pp. 203-226
Closed Access | Times Cited: 20
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13117-13146
Open Access | Times Cited: 2
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
Silvana Vasile, Anders Hallberg, Jessica Sallander, et al.
Biomolecules (2020) Vol. 10, Iss. 4, pp. 649-649
Open Access | Times Cited: 19
In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors
Veronica Salmaso, Kenneth A. Jacobson
Biomolecules (2020) Vol. 10, Iss. 6, pp. 812-812
Open Access | Times Cited: 19
Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure−Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations
Margarita Stampelou, Anna Suchankova, Eva Tzortzini, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13305-13327
Closed Access | Times Cited: 11
Adenosine Receptors: Structure, Distribution, and Signal Transduction
Stefania Merighi, Stefania Gessi, Pier Andrea Borea
Springer eBooks (2018), pp. 33-57
Closed Access | Times Cited: 17
Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition
Xuesong Wang, Willem Jespers, Rubén Prieto‐Díaz, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Medicinal Chemistry of A2B Adenosine Receptors
Christa E. Müller, Younis Baqi, Sonja Hinz, et al.
Springer eBooks (2018), pp. 137-168
Closed Access | Times Cited: 14
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists
Cristina Val, Carlos Rodríguez-García, Rubén Prieto‐Díaz, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2091-2106
Open Access | Times Cited: 6
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic KV7 channel openers: Exploration of a nicotinamide scaffold
Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Open Access | Times Cited: 6
Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations
Willem Jespers, Laura H. Heitman, Adriaan P. IJzerman, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 11, pp. e1009152-e1009152
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top